X
Access Company Profiles

Get business overview, business operations details specific to this market, products and services, latest developments and more...

Business Email

Select Companies

 

Anti-obesity Drugs Companies

This report lists the top Anti-obesity Drugs companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Anti-obesity Drugs industry.

Home Market Analysis Healthcare Research Pharmaceuticals Research Disease Specific Drugs Research Chronic Disorder Drugs Research Diabetes Care Drugs Research Obesity Treatment Market Companies

Anti-obesity Drugs Top Companies

  1. Vivus

  2. F Hoffmann-La Roche AG

  3. GlaxoSmithKline PLC

  4. Novo Nordisk AS

  5. Currax Pharmaceuticals LLC

*Disclaimer: Top companies sorted in no particular order

Anti-obesity Drugs Market Major Players

Anti-obesity Drugs Market Concentration

Anti-obesity Drugs Market Concentration

Anti-obesity Drugs Company List

                            • Alizyme

                            • Bayer AG

                            • Bristol-Myers Squibb

                            • Currax Pharmaceuticals LLC

                            • F. Hoffmann-La Roche AG

                            • GlaxoSmithKline PLC

                            • Merck & Co. Inc.

                            • Norgine BV

                            • Novo Nordisk AS

                            • Pfizer Inc.

                            • Rhythm Pharmaceuticals

                            • Takeda Pharmaceuticals

                            • Vivus Inc.

                            • Zafgan

                            • Zydus Cadila


                        Specific to Anti-obesity Drugs Market
                        Need More Details On Market Players And Competitors?
                        Download Sample

                        Anti-Obesity Drugs Market Report Snapshots

                        Anti-Obesity Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)